Antitumor effect by interleukin-11 receptor α-locus chemokine/CCL27, introduced into tumor cells through a recombinant adenovirus vector

Cancer Research

Volumn 63, Issue 15, 2003, Pages 4420-4425

  Gao, Jian Qing ^a   Tsuda, Yasuhiro ^a   Katayama, Kazufumi ^a   Nakayama, Takashi ^b   Hatanaka, Yutaka ^c   Tani, Yoichi ^c   Mizuguchi, Hiroyuki ^d   Hayakawa, Takao ^d   Yoshie, Osamu ^b   Tsutsumi, Yasuo ^a   Mayumi, Tadanori ^a   Nakagawa, Shinsaku ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c DakoCytomation Co Ltd   (Japan)

^d NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA CHEMOKINE; CCL27 CHEMOKINE; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FRACTALKINE; INTERLEUKIN 11 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; GENE THERAPY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; RECOMBINANT ADENOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES, CC; CHEMOKINES, CX3C; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNIZATION, PASSIVE; KILLER CELLS, NATURAL; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; OVARIAN NEOPLASMS;

EID: 0042090504     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Paillard, F. Cytokine and chemokine: a stimulating couple. Hum. Gene Ther., 10: 695-696, 1999.
2. Mule, J. J., Custer, M., Averbook, B., Yang, J. C., Weber, J. S., Goeddel, D. V., Rosenberg, S. A., and Schall, T. J. RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations. Hum. Gene Ther., 7: 1545-1553, 1996.
3. Strieter, R. M., Polverini, P. J., Arenberg, D. A., Walz, A., Opdenakker, G., Van Damme, J., and Kunkel, S. L. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J. Leukoc. Biol., 57: 752-762, 1995.
4. Hirose, K., Hakozaki, M., Nyunoya, Y., Kobayashi, Y., Matsushita, K., Takenouchi, T., Mikata, A., Mukaida, N., and Matsushima, K. Chemokine gene transfection into tumor cells reduced tumorigenicity in nude mice association with neutrophilic infiltration. Br. J. Cancer, 72: 708-714, 1995.
5. Huang, S., Xie, K., Singh, R. K., Gutman, M., and Bar-eli, M. Suppression of tumor growth and metastasis of murine renal adenocarcinoma by syngeneic fibroblasts genetically engineered to secret the JE/MCP-1 cytokine. J. Interferon Cytokine Res., 15: 655-665, 1996.
6. Laning, J., Kawasaki, H., Tanaka, E., Luo, Y., and Dorf, M. E. Inhibition of in vivo tumor growth by the beta chemokine, TCA3. J. Immunol., 153: 4625-4635, 1994.
7. Maric, M., and Liu, Y. Strong cytotoxic T lymphocyte responses to a macrophage inflammatory protein 1 α-expressing tumor: linkage between inflammation and specific immunity. Cancer Res., 59: 5549-5553, 1999.
8. Nakashima, E., Oya, A., Kubota, Y., Kanada, N., Matsushita, R., Takeda, K., Ichimura, F., Kuno, K., Mukaida, N., Hirose, K., Nakanishi, I., Ujiie, T., and Matsushima, K. A candidate for cancer gene therapy: MIP-1 alpha gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice. Pharm. Res., 13: 1896-1901, 1996.
9. Guo, J., Wang, B., Zhang, M., Chen, T., Yu, Y., Regulier, E., Homann, H., Qin, Z., and Ju, D. W. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity. Gene Ther., 9: 793-803, 2002.
10. Yoshie, O., Imai, T., and Nomiyama, H. Chemokines in immunity. Adv. Immunol., 78: 57-110, 2001.
11. Reiss, Y., Proudfoot, A. E., Power, C. A., Campbell, J. J., and Butcher, E. C. CC chemokine receptor (CCR) 4 and the CCR 10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J. Exp. Med., 194: 1541-1547, 2001.
12. Morales, J., Homey, B., Vicari, A. P., Hudak, S., Oldham, E., Hedrick, J., Orozco, R., Copeland, N. G., Jenkins, N. A., McEvoy, L. M., and Zlotnik, A. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc. Natl. Acad. Sci. USA, 96: 14470-14475, 1999.
13. 3C motif. Nature, 385: 640-644, 1997.
14. 3CR1, which mediates both leukocyte migration and adhesion. Cell, 91: 521-530, 1997.
15. 3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur. J. Immunol., 29: 2551-2559, 1999.
16. Okada, N., Saito, T., Masunaga, Y., Tsukada, Y., Nakagawa, S., Mizuguchi, H., Mori, K., Okada, Y., Fujita, T., Hayakawa, T., Mayumi, T., and Yamamoto, A. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells. Cancer Res., 61: 7913-7919, 2001.
17. Okada, Y., Okada, N., Nakagawa, S., Mizuguchi, H., Kanehira, M., Nishino, N., Takahashi, K., Mizuno, N., Hayakawa, T., and Mayumi, T. Fiber-mutant technique can augment gene transduction efficacy and antitumor effects against established murine melanoma by cytokine-gene therapy using adenovirus vectors. Cancer Lett., 177: 57-63, 2002.
18. Hashimoto, M., Niwa, O., Nitta, Y., Takeichi, M., and Yokoro, K. Unstable expression of E-Cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn. J. Cancer Res., 80: 459-463, 1989.
19. Mizuguchi, H., Kay, M. A., and Hayakawa, T. In vitro ligation-based cloning of foreign DNAs into the E3 and E1 deletion regions for generation of recombinant adenovirus vectors. Biotechniques, 30: 1112-1114, 2001.
20. Mizuguchi, H., Koizumi, N., Hosono, T., Utoguchi, N., Watanabe, Y., Kay, M. A., and Hayakawa, T. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the H1 loop of their fiber knob. Gene Ther., 8: 730-735, 2001.
21. Mizuguchi, H., and Kay, M. A. Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum. Gene Ther., 9: 2577-2583, 1998.
22. Rosenfeld, M, A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L. E., Paakko, P. K., Gilardi, P., Stratfold-Perricaudet, L. D., and Perricaudet, M. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science, 252: 431-434, 1991.
23. Crystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C. S., Mastrangeli, A., Hay, J. G., Brody, S. L., Jaffe, H. A., Eissa, N. T., and Danel, C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet., 8: 41-51, 1994.
24. Vicente-Manzanares, M., Montoya, M. C., Mellado, M., Frade, J. M., del Pozo, M. A., Nieto, M., de Landazuri, M. O., Martinez, A. C., and Sanchez-Madrid, F. The chemokine SDF-1 αtriggers a chemotactic response and induces cell polarization in human B lymphocytes. Eur. J. Immunol., 28: 2197-2207, 1998.
25. Kitching, A. R., Topping, P. G., Kurimoto, M., and Holdsworth, S. R. IL-18 has IL-12-independent effects in delayed-type hypersensitivity: studied in cell-mediated crescentic glomerulonephritis. J. Immunol., 165: 4649-4657, 2000.
26. Di Carlo, E., Comes, A., Basso, S., De Ambrosis, A., Meazza, R., Musiani, P., Moelling, K., Albini, A., and Ferrini, S. The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement. J. Immunol., 165: 3111-3118, 2000.
27. Homey, B., Alenius, H., Müller, A., Soto, H., Bowman, E. P., Yuan, W., McEvoy, L., Lauerma, A. I., Assmann, T., Bũnemann, E., Lehto, M., Wolff, H., Yen, D., Marxhausen, H., To, W., Sedgwick, J., Ruzicka, T., Lehmann, P., and Zlotnik, J. ILC-CCR10 interactions regulate T cell-mediated skin inflammatory. Nat. Med., 8: 157-165, 2002.
28. + cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J. Immunol., 168: 6173-6180, 2002.
29. Yoneda, O., Imai, T., Goda, S., Inoue, H., Yamauchi, A., Okazaki, T., Imai, H., Yoshie, O., Bloom, E. T., Domae, N., and Umehara, H. Fractalkine-mediated endothelial cells injury by NK cells. J. Immunol., 164: 4055-4062, 2000.
30. Volin, M. V., Woods, J. M., Amin, M. A., Connors, M. A., Harlow, L. A., and Koch, A. E. Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis. Am. J. Pathol., 159: 1521-1530, 2001.
31. Kolber, D. J., Knisely, T. L., and Maione, T. E. Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4. J. Natl. Cancer Inst. (Bethesda), 87: 304-309, 1995.
32. Tannenbaum, C. S., Tubbs, R., Amstrong, D., Finke, J. H., Bukowski, R. M., and Hamilton, T. A. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J. Immunol., 161: 927-932, 1998.
33. Sgadari, C., Farber, J. M., Angiolillo, A. L., Liao, F., Teruya-Feldstein, J., Burd, P. R., Yao, L., Gupta, G., Kanegane, C., and Tosato, G. Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo. Blood, 89: 2635-2643, 1997.
34. Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Glass, M., Burdick, M. D., and Strieter, R. M. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Investig., 97: 2792-2802, 1996.
35. + skin homing T cells. J. Immunol., 169: 1189-1196, 2002.
36. Mazzolini, G., Qian, C., Xie, X., Sun, Y., Lasarte, J. J., Drozdzik, M., and Prieto, J. Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12. Cancer Gene Ther., 6: 514-522, 2000.
37. + T cells in the antitumor immune response. J. Exp. Med., 188: 2357-2368, 1998.
38. Lanzavecchia, A. Immunology: license to kill. Nature, 393: 413-414, 1998.